Cardiac Resynchronization Therapy for Chemotherapy-Induced Cardiomyopathy
To the Editor Dr Singh and colleagues reported that patients with chemotherapy-induced cardiomyopathy (CHIC) who met class I or II indications for cardiac resynchronization therapy (CRT) showed improvement in left ventricular ejection fraction (LVEF) and heart failure symptoms by 6 months following CRT implantation. We would like to raise a few points for consideration.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Cardiomyopathy | Chemotherapy | General Medicine | Heart | Heart Failure